Valuation: 4DMedical Limited

Market Cap 1.29B 869M 793M 733M 661M 1.25B 81.22B 8.85B 3.5B 43.84B 3.26B 3.19B 138B P/E 2027 *
-32.9x
P/E 2028 * -67.9x
Enterprise Value 1.06B 710M 648M 599M 541M 1.02B 66.38B 7.23B 2.86B 35.83B 2.66B 2.61B 113B EV / Sales 2027 *
53.7x
EV / Sales 2028 * 21.2x
Free-Float
84.09%
Yield 2027 *
-
Yield 2028 * -
1 day+5.12%
1 week-2.16%
Current month-7.38%
1 month-41.60%
3 months-40.37%
6 months-38.08%
Current year-42.49%
1 week 2.02
Extreme 2.02
2.33
1 month 2.02
Extreme 2.02
3.92
Current year 2.02
Extreme 2.02
7.55
1 year 1.4
Extreme 1.4
7.55
3 years 0.22
Extreme 0.225
7.55
5 years 0.22
Extreme 0.225
7.55
10 years 0.22
Extreme 0.225
7.55
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - 28/10/2026
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member - 01/12/2012
Director/Board Member - 01/10/2017
Chairman - 28/10/2026
Date Insider Type Main position Quantity % Market Cap. Importance
18/6/26 Buy

Chief Financial Officer

13,054 0.0022%
4/3/26 Exercice

Director

213,464 0.0373%
4/3/26 Exercice

Director

213,464 0.0373%
Change 5-day change 1-year change 3-year change Capi.($)
+5.12%-2.16%+57.49%+218.31% 869M
+0.87%-3.48%+20.26%+48.52% 257B
+1.24%-2.86%+1.36%+10.01% 161B
-2.23%-6.36%-23.01%+37.89% 146B
+1.42%-3.30%-56.02%-19.69% 63.26B
-0.19%-0.55%+25.21%+57.29% 60.51B
+1.25%+0.74%+5.46%-12.39% 53.46B
+2.97%+0.21%+23.28%+56.72% 49.99B
-3.89%-9.05%+1.27%+57.02% 44.88B
+3.63%-1.02%+23.76%+77.98% 45.81B
Average +0.90%-3.98%+7.91%+53.17% 88B
Weighted average by Cap. +0.36%-3.96%+3.05%+34.36%

Financials

2027 *2028 *
Net sales 19.69M 13.22M 12.05M 11.15M 10.06M 18.94M 1.24B 135M 53.21M 667M 49.59M 48.55M 2.11B 51.1M 34.3M 31.29M 28.93M 26.1M 49.16M 3.21B 349M 138M 1.73B 129M 126M 5.46B
Net income -40.8M -27.39M -24.98M -23.09M -20.84M -39.25M -2.56B -279M -110M -1.38B -103M -101M -4.36B -19.34M -12.98M -11.84M -10.95M -9.88M -18.6M -1.21B -132M -52.25M -655M -48.7M -47.68M -2.07B
Net Debt -237M -159M -145M -134M -121M -228M -14.84B -1.62B -639M -8.01B -596M -583M -25.3B -212M -142M -130M -120M -108M -204M -13.3B -1.45B -573M -7.18B -534M -523M -22.67B
Projected Income Statement - Annual - 4DMedical Limited
Logo 4DMedical Limited
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Employees
181
Date Price Change Volume
19/11/26 $2.260 +5.12% 3,682,341
18/11/26 $2.150 +0.94% 3,198,173
17/11/26 $2.130 -2.74% 6,651,734
16/11/26 $2.190 -4.78% 3,482,634
13/11/26 $2.300 -0.43% 3,476,890
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - 4DMedical Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
2.150AUD
Average target price
4.167AUD
Spread / Average Target
+93.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - 4DMedical Limited